Keywords: boeh, ing, implores, germany, rewaed, innovation, after
Boeh Ing implores Germany to rewaed innovation after $285M R&D expansion
Article | 29 September 2003
Germany's Boehringer Ingelheim opened its new 255 million-euro ($289.7 million) R&D facility in Biberach, Germany, September 17, in what is the privately-held ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
